tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
Advertisement

Ascentage Pharma Group International (6855) Drug Pipeline

Compare
3 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Pld, Apg -2449
Advanced Solid Tumor, Platinum-Resistant Recurrent Ovarian Cancer
Phase I
Recruiting
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Nov 12, 2024
Azacitidine Injection, Lisaftoclax (Apg-2575)
Higher-Risk Myelodysplastic Syndrome
Phase III
Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Oct 12, 2024
Olverembatinib
Gist
Phase III
Recruiting
A Study of Olverembatinib in SDH-deficient GIST.
Oct 11, 2024
Olverembatinib, Bosutinib
Chronic Myeloid Leukemia, Cml, Cml, Chronic Phase
Phase III
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CP-CML
May 16, 2024
Azacitidine Injection, Apg-2575(Lisaftoclax )
Acute Myeloid Leukemia
Phase III
Recruiting
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Apr 24, 2024
Apg-2575
Sle
Phase I/II
Recruiting
A Study of APG-2575 in Patients with Mild-to-moderate Systemic Lupus Erythematosus.
Dec 03, 2023
Lisaftoclax +Btk Inhibitor, Btk Inhibitor
Cll/Sll
Phase III
Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
Oct 23, 2023
Imatinib, Olverembatinib
Ph+ All
Phase III
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
Sep 04, 2023
Apg-5918
Anemia
Phase I
Recruiting
A Study to Investigate the Safety, Pharmacokinetics and Efficacy of APG-5918 in Healthy Subjects or Anemic Patients
Feb 22, 2023
Apg-2575, Apg-115
Solid Tumor, Neuroblastoma
Phase I
Recruiting
APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors
Jan 18, 2023

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Ascentage Pharma Group International (6855) have in its pipeline
      6855 is currently developing the following drugs: Pld, Apg -2449, Azacitidine Injection, Lisaftoclax (Apg-2575), Olverembatinib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis